Non-alcoholic steatohepatitis (NASH) can lead to serious conditions such as cirrhosis and its complications, liver cancer and hepatic transplantation. Many patients eventually die from liver-related problems or cardiovascular disease. The challenge in developing drugs for NASH is to demonstrate an improvement in clinical outcomes. Cirrhosis takes several years to develop, …
![Clinical Outcomes in NASH](https://ddblog.labcorp.com/wp-content/uploads/2016/04/NASH-Article-Covance-BLOG.jpg)